Biogen Idec and Isis announce global collaboration for antisense program targeting myotonic dystrophy
Isis expands its rare disease franchise to include DM1...
Original Article: Biogen Idec and Isis announce global collaboration for antisense program targeting myotonic dystrophy
NEXT ARTICLE